TTR and amyloidosis: Successful examples of PEGylated lipid-based nanoparticles are given by the FDA approved mRNA vaccines of BioNTech and Moderna [113] or siRNA therapeutic ONPATTRO® for polyneuropathy in hereditary transthyretin-mediated (hATTR) amyloidosis [1].